Screener
BioLife Solutions BLFS Allowance for Doubtful Accounts Receivable (Current)
Allowance for Doubtful Accounts Receivable (Current) at other companies
Other financials
Where this comes from
Reported directly by BioLife Solutions in its filing.
Tagged under the XBRL concept us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent.
The source filing: BioLife Solutions’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:22 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054355
| (In thousands, except per share and share data) | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Current assets: | ||
| Cash and cash equivalents | $23,997 | $33,038 |
| Available-for-sale securities, current portion | 58,419 | 55,889 |
| Accounts receivable, trade, net of allowance for credit losses of $16 and $22 as of June 30, 2026 and December 31, 2025, respectively | 10,652 | 7,953 |
| Inventories | 35,591 | 30,155 |
| Prepaid expenses and other current assets | 6,539 | 9,526 |
| Total current assets | 135,198 | 136,561 |
| Property and equipment, net | 15,235 | 14,713 |
Item 1. Unaudited Condensed Consolidated Financial Statements
FAQ
- What is BioLife Solutions's allowance for doubtful accounts receivable (current)?
- BioLife Solutions (BLFS) reported allowance for doubtful accounts receivable (current) of $16K in Q2 2026.
- How has BioLife Solutions's allowance for doubtful accounts receivable (current) changed year-over-year?
- BioLife Solutions's allowance for doubtful accounts receivable (current) decreased by 88.1% year-over-year, from $134K to $16K.
- What is the long-term trend for BioLife Solutions's allowance for doubtful accounts receivable (current)?
- Over 3 years (2022 to 2025), BioLife Solutions's allowance for doubtful accounts receivable (current) has grown at a -69.0% compound annual growth rate (CAGR), from $739K to $22K.
- What does allowance for doubtful accounts receivable (current) mean?
- This is the valuation allowance for current receivables that are considered uncollectible due to disputes, bankruptcy, or other non-payment issues. It serves as a buffer against potential losses from customer defaults. It is a critical indicator of the health of the company's accounts receivable portfolio.
Ask your AI about BioLife Solutions's allowance for doubtful accounts receivable (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude